Workshop on Issues in the Design and Conduct of Clinical Trials of Antibacterial Drugs in the Treatment of Community-Acquired Pneumonia

Clinical Infectious Diseases  1 December 2008  V.47  N.s3

Indice

- Molecular Diagnostics for Detection of Bacterial and Viral Pathogens in Community-Acquired Pneumonia

http://www.journals.uchicago.edu/doi/abs/10.1086/591392

- Biological Markers to Determine Eligibility in Trials for Community-Acquired Pneumonia: A Focus on Procalcitonin

http://www.journals.uchicago.edu/doi/abs/10.1086/591393

- The Pneumonia Severity Index: A Decade after the Initial Derivation and Validation

http://www.journals.uchicago.edu/doi/abs/10.1086/591394

- Clinical End Points of Therapy for Patients with Mild Community-Acquired Pneumonia

http://www.journals.uchicago.edu/doi/abs/10.1086/591395

- Clinical Trial Design for Mild-to-Moderate Community-Acquired Pneumonia—An Industry Perspective

http://www.journals.uchicago.edu/doi/abs/10.1086/591399

- Clinical Trial Design and Selected Drug Safety Issues for Antibiotics Used to Treat Community-Acquired Pneumonia

http://www.journals.uchicago.edu/doi/abs/10.1086/591400

- Efficacy as an Important Facet of “Safety” in Clinical Trials: How Can We Do Our Best for Our Patients?

- Scenario 2: Community-Acquired Pneumonia Requiring Hospitalization but Not Requiring Admission to an Intensive Care Unit

http://www.journals.uchicago.edu/doi/abs/10.1086/591402

- Novel Approaches to the Identification of Streptococcus pneumoniae as the Cause of Community-Acquired Pneumonia

http://www.journals.uchicago.edu/doi/abs/10.1086/591405

- Is Activity against “Atypical” Pathogens Necessary in the Treatment Protocols for Community-Acquired Pneumonia? Issues with Combination Therapy

http://www.journals.uchicago.edu/doi/abs/10.1086/591409

- Clinical Trial Design and Consequences for Drug Development for Community-Acquired Pneumonia: An Industry Perspective

- Unique Considerations in the Evaluation of Antibacterials in Clinical Trials for Pediatric Community-Acquired Pneumonia

- Position Paper: Recommended Design Features of Future Clinical Trials of Antibacterial Agents for Community-Acquired Pneumonia

Solo abstracts

http://www.journals.uchicago.edu/toc/cid/47/s3